Search

Your search keyword '"Sandrucci, S."' showing total 21 results
Start Over Author "Sandrucci, S." Journal european journal of surgical oncology
21 results on '"Sandrucci, S."'

9. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma.

Author

Rubello, D., Pelizzo, M.R., Al-Nahhas, A., Salvatori, M., O'Doherty, M.J., Giuliano, A.E., Gross, M.D., Fanti, S., Sandrucci, S., Casara, D., and Mariani, G.

Subjects
CANCER patients, LYMPH nodes, CANCER, MEDLINE
Abstract

Abstract: Aim: To evaluate the “state of art” of clinical role of sentinel lymph node (SLN) biopsy procedure in patients affected by differentiated thyroid carcinoma. Methods: All papers cited on PubMed/MEDLINE until June 2005, published in English, and referred to the key words “sentinel lymph node biopsy” AND “thyroid carcinoma” OR “thyroid cancer” were reviewed for the purpose of the present study. Results: The first method used for SLN biopsy in thyroid carcinoma patients was the vital blue dye technique. This technique had some disadvantages as: (a) risk of disruption of the lymphatic channels deriving from the thyroid cancer; (b) difficulty in disclosing SLN lying outside the central compartment; (c) parathyroid glands can take up blue dye and, thus, can be misinterpreted as lymph nodes. Some of the above cited disadvantages were overcome by using the lymphoscintigraphy and intraoperative gamma probe technique. A combination of the blue dye and gamma probe technique has also been proposed with synergic results. Conclusion: The reported advantages of the SLN biopsy in small differentiated thyroid carcinoma patients can be resumed as follows: (a) better selection of patients who would benefit from compartment oriented nodal dissection; (b) more accurate lymph node staging; (c) better selection of patients who can require 131I treatment after surgery (SLN positive for metastasis); (d) better identification of SLN located out of the central compartment. [Copyright &y& Elsevier]

Published
2006
Full Text
View/download PDF

21. Perioperative nutrition and enhanced recovery after surgery in gastrointestinal cancer patients. A position paper by the ESSO task force in collaboration with the ERAS society (ERAS coalition)

Author

Nicolas Demartines, Kees Dejong, Geerard L. Beets, Marco Braga, Sergio Sandrucci, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Surgery, MUMC+: MA Heelkunde (9), Sandrucci, S, Beets, G, Braga, M, Dejong, K, and Demartines, N

Subjects
medicine.medical_specialty, BODY-COMPOSITION, Enhanced recovery after surgery, Frailty, Immunonutrition, Malnutrition, Mini-invasive surgery, Europe, Gastrointestinal Neoplasms, Guideline Adherence, Humans, Nutrition Assessment, Perioperative Care, Postoperative Complications, Nutritional Support, Surgery, Oncology, Context (language use), Clinical nutrition, ELECTIVE SURGERY, 03 medical and health sciences, 0302 clinical medicine, COLORECTAL SURGERY, Surgical oncology, medicine, RANDOMIZED-CLINICAL-TRIAL, MAJOR ABDOMINAL-SURGERY, Elective surgery, Intensive care medicine, SHORT-TERM OUTCOMES, RECTAL-CANCER, business.industry, LENGTH-OF-STAY, General Medicine, Perioperative, medicine.disease, Enhanced recovery after surgery, Frailty, Immunonutrition, Malnutrition, Mini-invasive surgery, Colorectal surgery, PANCREATIC-CANCER, 030220 oncology & carcinogenesis, Position paper, 030211 gastroenterology & hepatology, SURGICAL-PATIENTS, business
Abstract

Malnutrition in cancer patients in both prevalence and degree depends primarily on tumor stage and site. Preoperative malnutrition in surgical patients is a frequent problem and is associated with prolonged hospital stay, a higher rate of postoperative complications, higher re-admission rates, and a higher incidence of postoperative death. Given the focus on the cancer and its cure, nutrition is often neglected or under-evaluated, and this despite the availability of international guidelines for nutritional care in cancer patients and the evidence that nutritional deterioration negatively affects survival. Inadequate nutritional support for cancer patients should be considered ethically unacceptable; prompt nutritional support must be guaranteed to all cancer patients, as it can have many clinical and economic advantages. Patients undergoing multimodal oncological care are at particular risk of progressive nutritional decline, and it is essential to minimize the nutritional/metabolic impact of oncological treatments and to manage each surgical episode within the context of an enhanced recovery pathway. In Europe, enhanced recovery after surgery (ERAS) and routine nutritional assessment are only partially implemented because of insufficient awareness among health professionals of nutritional problems, a lack of structured collaboration between surgeons and clinical nutrition specialists, old dogmas, and the absence of dedicated resources. Collaboration between opinion leaders dedicated to ERAS from both the European Society of Surgical Oncology (ESSO) and the ERAS Society was born with the aim of promoting nutritional assessment and perioperative nutrition with and without an enhanced recovery program. The goal will be to improve awareness in the surgical oncology community and at institutional level to modify current clinical practice and identify optimal treatment options. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results